Zydus Wellness surges on getting CCI’s approval for acquisition of Heinz

Zydus Wellness surges on getting CCI’s approval for acquisition of Heinz

by admin- Wednesday, December 12th, 2018 03:58:43 PM

Zydus Wellness is presently trading at Rs. 1325.Forty, up through 21.45 points or 1.Sixty five% from its previous final of Rs. 1303.Ninety five on the BSE.

The scrip opened at Rs. 1310.10 and has touched a high and coffee of Rs. 1343.05 and Rs. 1310.10 respectively. So a long way 598 stocks were traded on the counter.

The BSE group ‘B’ inventory of face fee Rs. 10 has touched a fifty two week excessive of Rs. 1830.00 on 03-Sep-2018 and a 52 week low of Rs. 918.10 on 14-Dec-2017.

Last one week high and occasional of the scrip stood at Rs. 1,343.05 and Rs. 1,201.60 respectively. The contemporary marketplace cap of the organization is Rs. 5199.13 crore.

The promoters maintaining inside the organisation stood at seventy two.Fifty four%, while Institutions and Non-Institutions held 13.Sixty four% and thirteen.82% respectively.

Zydus Wellness (ZWL) has received approval from the Competition Commission of India (CCI) for the agency’s acquisition of Heinz India collectively with Cadila Healthcare.

The definitive settlement on the subject of this acquisition was signed on October 24, 2018.

ZWL will primarily be acquiring the enterprise related to the four brands – Glucon-D, Nycil, Sampriti and Complan, via this transaction. The CCI approval takes ZWL one step toward finishing the acquisition, that’s predicted to release substantial price for ZWL by enriching its portfolio and increasing the attain of its distribution network.

News Updates